131 related articles for article (PubMed ID: 8471205)
21. Kaposi's sarcoma as a sexually transmissible infection: an analysis of Australian AIDS surveillance data. The National HIV Surveillance Committee.
Elford J; McDonald A; Kaldor J
AIDS; 1993 Dec; 7(12):1667-71. PubMed ID: 8286078
[TBL] [Abstract][Full Text] [Related]
22. Trends and survival in AIDS-associated malignancies.
Casabona J; Salas T; Salinas R
Eur J Cancer; 1993; 29A(6):877-81. PubMed ID: 8484982
[TBL] [Abstract][Full Text] [Related]
23. Survival and mortality patterns of an acquired immunodeficiency syndrome (AIDS) cohort in New York State.
Chang HG; Morse DL; Noonan C; Coles B; Mikl J; Rosen A; Putnam D; Smith PF
Am J Epidemiol; 1993 Sep; 138(5):341-9. PubMed ID: 8356973
[TBL] [Abstract][Full Text] [Related]
24. Composite risk score for Kaposi's sarcoma based on a case-control and longitudinal study in the Multicenter AIDS Cohort Study (MACS) population.
Armenian HK; Hoover DR; Rubb S; Metz S; Kaslow R; Visscher B; Chmiel J; Kingsley L; Saah A
Am J Epidemiol; 1993 Aug; 138(4):256-65. PubMed ID: 8356966
[TBL] [Abstract][Full Text] [Related]
25. The UK register of HIV seroconverters: methods and analytical issues. UK register of HIV seroconverters (UKRHS) Steering Committee.
Epidemiol Infect; 1996 Oct; 117(2):305-12. PubMed ID: 8870628
[TBL] [Abstract][Full Text] [Related]
26. Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study Group.
Mocroft AJ; Lundgren JD; d'Armino Monforte A; Ledergerber B; Barton SE; Vella S; Katlama C; Gerstoft J; Pedersen C; Phillips AN
Int J Epidemiol; 1997 Apr; 26(2):400-7. PubMed ID: 9169177
[TBL] [Abstract][Full Text] [Related]
27. HIV-1 disease progression and AIDS-defining disorders in rural Uganda.
Morgan D; Maude GH; Malamba SS; Okongo MJ; Wagner HU; Mulder DW; Whitworth JA
Lancet; 1997 Jul; 350(9073):245-50. PubMed ID: 9242801
[TBL] [Abstract][Full Text] [Related]
28. The role of initial AIDS-defining illness in survival following AIDS.
Luo K; Law M; Kaldor JM; McDonald AM; Cooper DA
AIDS; 1995 Jan; 9(1):57-63. PubMed ID: 7893442
[TBL] [Abstract][Full Text] [Related]
29. Survival analysis of hemophilia-associated AIDS cases in the US.
Stehr-Green JK; Holman RC; Mahoney MA
Am J Public Health; 1989 Jul; 79(7):832-5. PubMed ID: 2735467
[TBL] [Abstract][Full Text] [Related]
30. Transfusion associated AIDS in Mexico. Clinical spectrum, conditional latency distribution, and survival.
Volkow P; Ponce de León S; Calva J; Ruiz-Palacios G; Mohar A
Rev Invest Clin; 1993; 45(2):133-8. PubMed ID: 8337540
[TBL] [Abstract][Full Text] [Related]
31. The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
Bower M; Weir J; Francis N; Newsom-Davis T; Powles S; Crook T; Boffito M; Gazzard B; Nelson M
AIDS; 2009 Aug; 23(13):1701-6. PubMed ID: 19550283
[TBL] [Abstract][Full Text] [Related]
32. Mortality Risk After AIDS-Defining Opportunistic Illness Among HIV-Infected Persons--San Francisco, 1981-2012.
Djawe K; Buchacz K; Hsu L; Chen MJ; Selik RM; Rose C; Williams T; Brooks JT; Schwarcz S
J Infect Dis; 2015 Nov; 212(9):1366-75. PubMed ID: 26044289
[TBL] [Abstract][Full Text] [Related]
33. Effect of the revised AIDS case definition on AIDS reporting in San Francisco: evidence of increased reporting in intravenous drug users.
Payne SF; Rutherford GW; Lemp GF; Clevenger AC
AIDS; 1990 Apr; 4(4):335-9. PubMed ID: 2350453
[TBL] [Abstract][Full Text] [Related]
34. The association between cigarette smoking and selected HIV-related medical conditions.
Conley LJ; Bush TJ; Buchbinder SP; Penley KA; Judson FN; Holmberg SD
AIDS; 1996 Sep; 10(10):1121-6. PubMed ID: 8874629
[TBL] [Abstract][Full Text] [Related]
35. Bronchopulmonary Kaposi's sarcoma in patients with AIDS.
Mitchell DM; McCarty M; Fleming J; Moss FM
Thorax; 1992 Sep; 47(9):726-9. PubMed ID: 1440468
[TBL] [Abstract][Full Text] [Related]
36. The practical significance of potential biases in estimates of the AIDS incubation period distribution in the UK register of HIV seroconverters.
Porter K; Johnson AM; Phillips AN; Darbyshire JH
AIDS; 1999 Oct; 13(14):1943-51. PubMed ID: 10513654
[TBL] [Abstract][Full Text] [Related]
37. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe.
Lancet; 2000 Apr; 355(9210):1131-7. PubMed ID: 10791375
[TBL] [Abstract][Full Text] [Related]
38. Impact of the 1993 revision of the AIDS case definition on the prevalence of AIDS in a clinical setting.
Chaisson RE; Stanton DL; Gallant JE; Rucker S; Bartlett JG; Moore RD
AIDS; 1993 Jun; 7(6):857-62. PubMed ID: 8103343
[TBL] [Abstract][Full Text] [Related]
39. Geographic and birth cohort associations of Kaposi's sarcoma among homosexual men in Canada.
Schechter MT; Marion SA; Elmslie KD; Ricketts MN; Nault P; Archibald CP
Am J Epidemiol; 1991 Sep; 134(5):485-8. PubMed ID: 1897504
[TBL] [Abstract][Full Text] [Related]
40. Survival after diagnosis of AIDS among adults resident in the United Kingdom in the era of multiple therapies.
Rogers PA; Sinka KJ; Molesworth AM; Evans BG; Allardice GM
Commun Dis Public Health; 2000 Sep; 3(3):188-94. PubMed ID: 11014033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
